Welcome back to Endpoints Weekly! This week, we opened nominations for our eighth annual Women in Biopharma report. We’re looking to profile 20 scientists, executives, founders and ...
June 13, 2026 06:00 AM EDT
Weekly
Biopharma’s 2025 industry pay report; Parabilis sets industry record IPO; and more
Nicole DeFeudis
Max Gelman
'Biopharma ecosystem is back to full health,' fueled by M&A: PwC
Hope for Kendall Square’s lab market
PSG report examines payers and employers’ attitudes towards GLP-1 coverage, unbundling’ PBM models
Parabilis sets a record with a $670M biotech IPO
Why one health system invested in its PBM as GLP-1 costs surged
The legacy approach to real-world data is costing you
A New Blueprint: Innovations in DNA Synthesis
ARCH-launched Neumora stops depression program
Endpoints News opens nominations for its 2026 Women in Biopharma project, spotlighting scientists, executives and founders making…
Endpoints launches its annual biopharma pay project; Andrew Dunn and Drew Armstrong break down CEO compensation live on June 9,…
The typical worker in biopharma made $116,648 in 2025, according to an Endpoints News pay analysis, earning about 30% more than…
With pharma and life sciences deal values surpassing $65 billion in Q1, marking the strongest quarter in the industry since 2020,…
Drug pricing in Europe, AI deals for VC firms, and more biotech news from The Readout
New guidance for gene therapy developers, Lilly's deal for kidney drugs, and more biotech news from The Readout
